Company: Teva Pharmaceutical Industries
Drug Type: Protein Biologic
Mechanism Type: Immunomodulation
Mechanism: Copaxone is a synthetic protein composed of four amino acids found in myelin basic protein (MBP). The drug simulates MBP, and prevents damage to myelin caused by T-cells.
U.S. Status for ALS: Discontinued
 Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS). ClinicalTrials.gov, 29 Aug 2013. Accessed 11 Mar 2016 from https://clinicaltrials.gov/ct2/show/NCT00326625.
 Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial. Meininger, V et al. Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):378-83.
Last updated March 11th, 2016